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The expression of estrogen receptor (ER) in thymocytes was studied in young, middle-aged, and
old (2, 12, and 24 months, respectively) female and male C57BL/6J mice. Western immunoblots
prepared from the thymocytes of females of all age groups showed the presence of a 67-kD
protein band, which has been associated with the apparentMW of denatured ER. Flow cytometry
analysis o,f cells stained with a monoclonal anti-ER antibody (clone 13H2) disclosed ER
expression in both females and males of all age groups. In vivo treatment with estradiol (E2) led
to an increase in the specific activity of thymic creatine kinase (CK) in the female mice, whereas
the male thymocytes responded with an increase in CK activity only on treatment with
dihydrotestosterone (DHT). The data show no differences in ER expression between male and
females, but the receptor appears not to be functional in males. Interestingly, when estradiol was
applied to co-cultures of lymphoid-depleted fetal thymus (FT) explants and bone-marrow cells,
or thymocytes, from young and old females, it resulted in increased cellularity of cultures
containing cells of the young, and not those of the old. The proportion of CD4/CD8 phenotypes
of the developing cells in these cultures was not affected by E2 treatment. These observations
provide a new insight into ER expression and function in T-cell development in relation to
gender and age.
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INTRODUCTION
The idea that gonadal steroids play a role in
immunological dimorphism has gained support from
various studies (Grossman, 1985, 1989; Marchetti et
al., 1995; Sthoeger et al., 1988; Besedovsky and del
Rey, 1996). Estrogen binding was shown in human
peripheral blood mononuclear cells (Danel et al.,
1983; Weusten et al., 1986) and in the thymus (Danel
et al., 1983; Gulino et al., 1983, 1985; Luster et al.,
1984; Marchetti et al., 1984; Weusten et al., 1986).
Expression of ER in the thymus was found mainly in
the epithelial cells (Luster et al., 1984; Marchetti et
al., 1984), suggesting the involvement of estrogen
function in T-lymphocyte development. In previous
studies, using a variety of experimental criteria, we
demonstrated that ER is expressed in thymocytes of
young adult female mice and rats (Amir-Zaltsman et
al., 1993). Hence, (1) Western blot analysis of
thymocytes showed the presence of a 67-kD protein
band; (2) Northern blot analysis of poly(A+)-enriched
RNA fraction obtained from the thymocytes showed
the presence of a transcript of 6.2 kb, corresponding
to the size of ER mRNA; (3) immunofluorescence
studies using anti-idiotypic antibody clone 1D5 that
interacts with ER (Mor et al., 1992) showed staining
of the thymocyte nuclei; (4) the mitogen-induced
proliferative response was reduced in the presence of
estradiol; (5) administration of estradiol to immature
female rats caused a significant increase in the thymic
ER mRNA and Creatine kinase B (CKb) mRNA
(Amir-Zaltsman et al., 1993).
The function of estrogen in the immune system has
been of particular interest, in view of its relevance to
pregnancy (Clarke and Kendall 1994) and autoim-
munity (Cutolo et al., 1995). In addition, since
generation ofT lymphocytes continues throughout the
lifespan, a decline in ER expression in the aging
thymus may play a role in developmental processes
that change with age (Globerson 1994, 1995). How-
ever, there is hardly any information on the status of
ER in the aging thymus.
The present study was designed to determine
whether the expression and function of ER in
thymocytes are age- and gender-specific and to
examine its role in lymphoid development in the
thymus.
RESULTS
Expression of ER in Thymocytes
The first series of experiments was conducted to
examine the expression of ER in thymocytes of
female and male mice, as related to age. We used
Western immunoblots and flow cytometry methods,
as in our previous report (Amir-Zaltzman et al.,
1993).
Western immunoblots prepared from thymocytes
of female mice showed the presence of a 67-kD
protein band (lane A in Figure l a), which has been
associated with the apparent MW of denatured ER
(Greene et al., 1986). This band was observed in
thymocytes of the three age groups (lanes B, C, and D
in Figure a), and was absent when the primary,
specific anti-E2 antibody was omitted in the control
gel (Figure b). The specific anti-E2 antibody stained
the 32-kD fragment in the thymocytes of all mice in
the group (lanes B, C, and D in Figure a) and was
absent in the control blot (lanes B, C, D, and E in
Figure lb).
Representative flow cytometry profiles of thymo-
cytes from young and old females show specific
staining with the anti-ER antibody and PE-rabbit anti-
mouse IgG, as related to the control of second
antibody alone. Similar results were obtained with
FITC-labeled goat anti-mouse IgG as a second
antibody (Figure 2) or when the directly labeled
FITC-anti-ER antibody was used (data not shown).
Analysis of thymocytes from females and males of
the different age groups revealed a similar proportion
of ER cells in all cases (Table I).
Response to Gonadal-Hormone Treatment In
Vivo
Functional manifestation of ER in thymocytes was
investigated in hormone-treated mice, by measuring
the CK-response studies. Female and male mice of theESTROGEN RECEPTOR-EXPRESSIO 279
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FIGURE Mouse thymocyles (2 105 cells/lane), cDNA estrogen-receptor (ER) protein expressed in yeast and the 32-kD purified ER
fragment from porcine uteri were subjected to 10% SDS-PAGE and transferred to nitrocellulase and probed first with anti-ER antibody
(clone 13H2), followed with rabbit anti-mouse IgG1 peroxidase conjugate as described (Amiz-Zaltsman, et al, 1993). The blots were then
visualized using enhanced chemiluminescence, and the reagents provided by Amersham. Mol wt markers are shown on the right. (a) Lane
A: cDNA ER protein expressed in yeast. Lane B: Mouse thymocytes derived from a 2-month-old C57BL female mouse. Lane C: Mouse
thymocytes derived from a 1-year-old C57BL female mouse. Lane D: Mouse thymocytes derived from a 2-year-old C57BL female mouse.
Lane E: The 34-kD ER fragment derived from porcine uteri. (b) Controls of lanes A through D probed only with the second antibody rat
anti-mouse IgG peroxidase.
different age groups were injected with either E2,
DHT, or PBS, respectively. Analysis of CK response
to hormonal treatment was performed on the intact
thymus tissue, to correlate with previous studies
(Marchetti et al., 1984), as well as on separated
thymocytes, leading to similar results. Figure 3 shows
representative results obtained on intact thymus
tissue. Hence, CK levels were increased in females
treated with E2 and not with DHT, whereas the males
showed a response to DHT and not to E2. The sex-
specific-induced increase in CK response in the
thymus (Figure 3) and in isolated thymocytes (data
not shown) was observed in all age groups.
Effects of E2 on Thymocytopoiesis In Vitro
To find out if ER expression plays any role in
thymocytopoiesis, we seeded thymocytes and bone-
marrow cells, from young and old female mice, onto
individual lymphoid-depleted FT lobes. E2 was
applied for the first 3 days of cell seeding onto the FT
lobes (under the "hanging-drop" conditions), or
during the subsequent organ culture period, or
throughout the entire in vitro period. Control cultures
were set up in parallel, without E2. The cultures were
sacrificed after 7 days, and cell numbers were
counted. In addition, cells were analyzed for CD4/
CD8 phenotypes, using a direct double-staining280 E KOHEN et al.
procedure. The results showed a significant increase
in numbers of cells originating from young donors,
following incubation with E2 during the seeding phase
of the culture. No effect was observed in any of the
cultures of old donor cells (Table II). On the other
hand, the proportions of CD4/CD8 phenotypes were
not affected by E2 treatment (Table III).
DISCUSSION
Expression of ER in the thymus has been demon-
strated in the past; however, there has been little
information on its expression and function in aging.
Our results provide new information regarding ER in
relation to gender and age. Whereas ER is expressed
in both females and males, only female cells respond
to estrogen. Regarding aging, we observed no signifi-
cant age-related decline in ER expression, as revealed
from Western immunoblots, flow cytometry, and CK
response. It thus appeared that ER continues to
function in advanced age. However, experiments
designed to determine ifER expression in aging plays
a role in thymocytopoiesis showed that E2 treatment
resulted in cellular expansion in the young, but not in
the old donor-derived thymocytes.
The finding that thymocytes of male mice express
the ER, with no increase in CK activity in response to
treatment with E2, suggests that the ER in males is not
functional. On the other hand, the male thymocytes
responded to DHT, indicating the presence of func-
tional androgen receptors in this organ. These findings
are in accordance with the previous results on skeletal
cells, where E2 caused specific stimulation of CK
activity only in female- and not in male-derived
skeletal cells, whereas the male cells responded to
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FIGURE 2 Flow cytometry profiles of ER thymocytes of young (2 months) and old (24 months) C57BL/6J females. (Curve A)
Background control cells stained with the second antibody only. (Curve B) Thymocytes stained in a two-step procedure, using monoclonal
anti-ER antibodies (13H2 clone) and PE-labeled rabbit anti-mouse IgG. Y axis: cell number (arbitrary units).ESTROGEN RECEPTOR-EXPRESSION 281
TABLE Flow Cytometry Analysis of ER Expression in Thymocytes of Females and Males of Different Age Groups
ER cells (%)a
Age (months) Females’ Males
2 68 +_ 15 59 12
12 67 9 64 10
24 72 7 74 6
aValues represent mean SD of percent ER+ thymocytes from six individual mice per group, calculated from two-step staining with an anti-
ER monoclonal antibody (13H2) and subsequently with a second step of either FITC-goat anti-mouse or RPE-Rabbit anti-mouse IgG. Mice
of all the age groups were examined in parallel in each of three independent experiments.
DHT (S6mjen et al., 1995). Interestingly, it was
recently shown that estrogen resistance caused by a
mutation in the ER gene in a 28-year-old man resulted
in osteoporosis, implicating a role of ER in males
(Smith et al., 1994). Our finding that ER is expressed
in males, yet, it is not functional in response to E2, as
manifested in the CK assay, raises the question of
whether it has other possible functions.
Estrogens influence many developmental and
physiological responses in target cells by regulating
specific gene activity (Parker, 1993). Expression of
the receptor in thymic epithelial cells may play a role
in processes of stromal-cell induction of lymphocyte
development, whereas expression in the thymic
lymphoid cells also sug,gests direct hormonal effects
on these cells. Estrogen may thus affect various types
of processes in the thymus, including cell division,
differentiation, and apoptosis, either directly or via
stimulation of cytokine function. Our present study
reveals a role of ER on cell division, and no effect on
thymocyte subset differentiation, as indicated from
the results on young donor cells. The observation of
no effect on cell division in case of the old may be
attributed to downstream processes that decrease in
aging (Globerson, 1995). The mechanisms underlying
the functional manifestation and the immunological
relevance of the receptor in thymocytes, as well as the
nature of the ER in males, will need to be further
elucidated.
MATERIALS AND METHODS
Mice
Young (2 to 3 months), middle-aged (12 months), and
old (24 months) female and male C57BL/6J (Jackson
Laboratories, Bar Harbor, ME) and BALB/c mice
(OLAC, UK) were used throughout the study. The
mice were virus- and pathogen-free (SPF), bred in
isolators, and maintained in Millipore-top cages, on
sterile bedding, with food and water ad libitum.
Cleaning and handling were performed under laminar
flow hoods. The mice were routinely monitored for
possible viral, bacterial, or parasitic contaminations.
Only mice with no overt malignancy or any other
gross pathological manifestation were included in the
study.
Western Blot Analysis
Mouse thymocytes (2 105 cells/lane), the 32-kD ER
fragment purified from porcine uteri (Thole et al.,
1991) and the cDNA ER protein expressed in yeast
(Greene et al., 1986) were solubilized in buffer
containing 0.07M TrisHC1, pH 6.8, 10% glycerol, 1%
SDS, /3-mercaptoethanol, and bromophenol blue by
heating at 100C for 5 min, and processed for Western
blot analysis as described previously (Amir-Zaltsman
et al., 1993).
Antibodies
Mouse monoclonal antibody, clone 13H2, raised
against porcine 32-kD hormone-binding estrogen
receptor (ER) fragment (Thole et al., 1991; Thole and
Jakob, 1993) was prepared as described previously.
This antibody was conjugated with FITC for direct
staining of thymocytes in flow cytometry, using
conditions previously described (Mot et al., 1992).
Rabbit anti-mouse IgG1 peroxidase and FITC-labeled
goat anti-mouse IgG were from Zymed Lab. (South
San Francisco) and rabbit anti-mouse RPE, affinity-282 F. KOHEN et al.
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FIGURE 3 Hormonal stimulation of CK-specific activity in mouse thymus. Young and old, female and male mice were injected with E2,
DTH, or PBS, as described in Materials and Methods. The thymus of each mouse was then assayed for CK-specific activity. Results are
expressed as mean S.E.M.; n 5; *P --< 0.05.ESTROGEN RECEPTOR-EXPRESSION 283
TABLE II Effect of E2 on In Vitro T-Cell Development from Cells of Young and Old Mice
Cells/lobe 103
Donor cells Age group n E2 Control P value
Thymocytes Young 13 46.0 +/- 3.0 31.4 +/- 3.0 0.005
Old 13 27.7 2.5 29.9 +/- 4.4 NS
Bone marrow Young 8 45.1 +/- 7.4 30.8 4.2 0.02
Old 8 27.8 +/- 3.5 29.8 6.0 NS
apNA+ thymocyte populations, representing immature cells.
Note: Thymocytes, or bone-marrow cells, from young and old mice, were co-cultured with lymphoid depleted fetal thymus lobes.
Data represent mean SE values calculated from data obtained in independent experiments (n). Each experiment included sets of cultures
with cells from individual young and old donor mice.
TABLE III CD4/CD8 Subsets in Co-Cultures of FT and Bone-Marrow Cells from Young and Old Donors Treated with E2
Subset E2 Young control E2 Old control
CD4+CD8 10.1 +/- 0.7 12.2 +/- 5.4 8.3 +/- 1.9 6.2 +/- 1.8
CD4-CD8 12.5 2.2 13.0 +/- 0.8 22.0 +/- 3.1 22.8 +/- 5.9
CD4/CD8 10.6 +/- 1.8 8.1 +/- 2.0 14.6 +/- 6.6 14.5 +/- 4.4
CD4-CD8- 66.3 +/- 4.5 69.0 +/- 5.4 51.3 +/- 6.7 56.4 8.8
Mean +/- SE values of five independent experiments.
Note: BM cells were seeded onto irradiated FT explants hr after exposure. E2 was applied during the first 2 days in hanging-drop cultures.
Cells were harvested for analysis after 7 days in organ cultures.
isolated F(ab-)2 conjugate was from Dako (Den-
mark). Anti-mouse CD4 conjugated with PE and
FITC-anti-mouse CD8 (Serotec, UK) were used in
direct double staining.
Hormonal Treatment In Vivo
The changes in creatine kinase (CK) specific activity
in the thymus induced by the short treatment of
estradiol (E2), dihydrotestosterone (DHT), or phos-
phate-buffered saline (PBS, control) were studied in
male and female mice of the three age categories. The
animals (five mice/group) were sacrificed 24 hr after
i.p. injection of E2 (5 /zg/animal), DHT (10 #g/
animal), or PBS.
Hormonal Treatment In Vitro
Organ cultures were prepared as originally described
(Eren et al., 1988). Briefly, fetal (day 14 of gestation)
thymus (FT) lobes were depleted of lymphoid cells by
treatment with 2-deoxyguanosine (1.35 mM) for 5
days at 37C (Jenkinson et al., 1982), or by exposure
to irradiation (20 Gy; Fridkis-Hareli et al., 1991), as
specified. The FT lobes were subsequently incubated
with the donor cells (60 103 cells/lobe), in hanging
drops, in Terasaki plates (Nunclon; Denmark), for 3
days; then rinsed and cultivated in organ cultures for
7 days. Donor cells included bone marrow, or
immature (PNA+) thymocytes, prepared in accord-
ance to standard procedures (Reisner et al., 1976).
Hormonal treatment (10
-7 M E2) to the cultures was
applied either in the hanging drops, or in the organ
cultures, or throughout the in vitro incubation
period.
Flow Cytometry Analysis
Thymocytes, prepared from each mouse separately (2
X 106 cells/pellet), were fixed in 50% ethanol at
-20C for 10 min. The cells were stained directly
(with FITC-anti-ER), or in a two-step procedure,
using PE-labeled rabbit anti-mouse IgG as the second
antibody. Incubation with the 13H2 monoclonal
antibody (unlabeled, or FITC-conjugated; 20/zl from
a stock solution of 100/zg protein/ml PBS containing284 E KOHEN et al.
0.1% BSA and 5% fetal calf serum) was carried out at
4C for 45 min. Staining with the flurochrom-
conjugated anti-mouse IgG (20 1 of the stock
solution) was under similar conditions. Cells incu-
bated with the second antibody alone served as
negative control. Flow cytometry was performed on a
FACScan (Becton-Dickinson, Mountain View, CA),
using the PCLYSYS II program for analysis of the
data.
Analysis of CK Activity
Analysis of CK activity was carried out on the intact
thymus tissue, thymocytes, or thymic stromal tissue;
stored at -20C and processed as previously
described (S6mjen et al., 1995).
Data Analysis
Experimental groups consisted of five mice. Data
present were mean + SE of at least two independent
experiments, as specified. Statistical analysis was
based on Student’s test.
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